Ophthalmology · Annapolis, MD
NPI
1255338307
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
127 Lubrano Dr, Suite 301
Annapolis, MD, 21401
Phone (410) 224-2010
Groups this clinician bills Medicare through
Medicare paid, 2024
$648K
9,801 services
Medicare patients, 2024
2,211
Average age 75
Drug cost, 2024
$742K
2,725 prescriptions
Company payments, 2025
$2,891
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel F Boles was code 92250 (angiography), 1,993 times for 1,921 patients. In total Samuel F Boles billed 9,801 services in 35 codes, and Medicare paid $648K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 1,993 | 1,921 | $24.61 | $49K |
| 92014 Ophthalmological E&M | Office | 1,706 | 1,589 | $81.30 | $139K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,449 | 1,349 | $44.33 | $64K |
| 92020 Ophthalmological E&M | Office | 1,173 | 1,129 | $20.56 | $24K |
| 92012 Ophthalmological E&M | Office | 891 | 699 | $59.62 | $53K |
| 92133 Computerized Ophthalmic Imaging | Office | 578 | 565 | $24.24 | $14K |
| 92004 Ophthalmological E&M | Office | 405 | 405 | $96.52 | $39K |
| 92136 Ultrasound - Nonspecific | Office | 354 | 274 | $29.91 | $11K |
| 92134 Computerized Ophthalmic Imaging | Office | 341 | 335 | $29.79 | $10K |
| 76514 Ultrasound - Nonspecific | Office | 239 | 239 | $8.22 | $1,964 |
| 66982 Cataract Surgery | Facility | 214 | 137 | $568.07 | $122K |
| 66984 Cataract Surgery | Facility | 177 | 113 | $417.76 | $74K |
| 66821 Cataract Surgery | Facility | 111 | 82 | $248.43 | $28K |
| 66761 Fluid Flow and Drainage of Eye (Any Method) | Facility | 38 | 22 | $189.26 | $7,192 |
| 99211 Office E&M - Established | Office | 33 | 32 | $16.90 | $558 |
By year: 2022 $726K for 9,834 services; 2023 $695K for 9,955 services; 2024 $648K for 9,801 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel F Boles prescribed most often to Medicare patients was Latanoprost, with 724 prescriptions and refills. In total Samuel F Boles wrote 2,725 Medicare prescriptions that cost $742K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 724 | 1,750 | 231 | $10K |
| Lumigan Bimatoprost | 325 | 753 | 107 | $194K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 227 | 471 | 54 | $3,847 |
| Simbrinza Brinzolamide/Brimonidine Tart | 155 | 244 | 41 | $36K |
| Travoprost Generic | 138 | 350 | 50 | $46K |
| Loteprednol Etabonate Generic | 131 | 131 | 97 | $19K |
| Dorzolamide Hcl Generic | 123 | 289 | 41 | $2,195 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 100 | 201 | 28 | $78K |
| Vyzulta Latanoprostene Bunod | 96 | 193 | 39 | $58K |
| Tobradex St Tobramycin/Dexamethasone | 72 | 73 | 55 | $16K |
| Brimonidine Tartrate Generic | 70 | 181 | 26 | $3,563 |
| Prednisolone Acetate Generic | 57 | 73 | 44 | $2,200 |
| Combigan Brimonidine Tartrate/Timolol | 56 | 136 | 18 | $30K |
| Rhopressa Netarsudil Mesylate | 55 | 108 | 18 | $38K |
| Timolol Maleate Generic | 43 | 114 | 17 | $530 |
Brand drugs: 1,494 claims; generic drugs: 1,231 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel F Boles $2,891 ($2,891 in general payments such as food, travel and fees) from 17 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $543.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 11 | $543 |
| Abbvie Inc. ABBV | 14 | $446 |
| Lumenis BE inc | 1 | $321 |
| Alcon Vision LLC ALC | 10 | $314 |
| Amgen Inc. AMGN | 6 | $256 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $191 |
| Harrow Eye, LLC | 7 | $176 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $135 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $135 |
| Thea Pharma Inc. | 3 | $66.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.